ArticleCell death & disease2019

CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.

Yang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.